With Congress back in session, the landscape of American health policy is already fraught with tension. To unravel these complex issues, we're joined by Faisal Zain, a leading expert in healthcare policy and technology. His work provides a crucial lens through which to understand the intricate
From Digital Health Player to Potential Market Disruptor In the dynamic and fiercely competitive telehealth sector, LifeMD Inc. (LFMD) is charting a compelling course that has captured significant investor attention by pursuing a potent, two-pronged strategy. The company is rapidly transforming
The reverberations from Insilico Medicine's blockbuster public offering continue to reshape the investment landscape, cementing the role of artificial intelligence not as a future aspiration for biotechnology, but as its present-day engine of value and innovation. This successful debut on the
The fierce competition for skilled professionals has long driven innovation in compensation packages, but the recent enactment of landmark legislation is now fundamentally reshaping the strategic value and structure of employee benefits. With the provisions of the One Big Beautiful Bill Act of 2025
The rapid infusion of artificial intelligence into healthcare has created a perplexing economic reality where unprecedented technological investment coexists with deteriorating financial outcomes for providers. While AI-powered ambient scribes have been celebrated for their potential to alleviate
Today we’re speaking with Faisal Zain, a leading expert in healthcare policy and economics. A recent SHADAC report has sent ripples through the industry, revealing that employer-sponsored health insurance costs are surging faster than inflation, placing an immense burden on American families and b
